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Microcin J25 (MccJ25) is a gene-encoded lasso
peptide secreted by Escherichia coli which ex-
erts a potent antibacterial activity by blocking
RNA polymerase. Here we demonstrate that
McjB and McjC, encoded by genes in the
MccJ25 gene cluster, catalyze the maturation
of MccJ25. Requirement for both McjB and
McjCwas shown by gene inactivation and com-
plementation assays. Furthermore, the conver-
sion of the linear precursor McjA into mature
MccJ25 was obtained in vitro in the presence
of McjB and McjC, all proteins being produced
by recombinant expression in E. coli. Analysis
of the amino acid sequences revealed that
McjB could possess proteolytic activity,
whereas McjC would be the ATP/Mg2+-depen-
dent enzyme responsible for the formation of
the Gly1-Glu8 amide bond. Finally, we show
that putative lasso peptides are widespread
among Proteobacteria and Actinobacteria.
INTRODUCTION
Many molecules from bacteria endowed with a broad
spectrum of biological activities are biosynthesized
through a cyclization process [1]. Lasso peptides [2] are
16–21 residue naturally occurring peptides that result
from both cyclization and acquisition of a typical and com-
plex structure [2–7]. A side chain to backbone cyclization
leads to an amide bond between the amino group of an
N-terminal Gly/Cys residue and the carboxyl group of
a Glu/Asp residue at position 8 or 9. The C-terminal tail of
the peptide is irreversibly trapped in the ring, thus forming
a lasso. Lasso peptides are classified according to the
occurrence or not of disulfide bonds [8]. Class I is formed
by peptides that contain four cysteine residues at con-
served positions [2, 4], whereas class II is formed by pep-
tides devoid of cysteine, in which position 1 is always
occupied by a glycine [3, 5–8]. Most lasso peptides have
been isolated from Actinobacteria and were shown to beChemistry & Biology 14,enzyme inhibitors [2–6]. Recently, a Rhodococcus strain
was shown to produce class II lasso peptides with antimy-
cobacterial properties [7]. However, little is known about
the enzymes involved in the biosynthesis of lasso peptides.
Microcin J25 (MccJ25) is a typical class II lasso peptide
[9–11]. It is a gene-encoded antibacterial peptide secreted
by Escherichia coli AY25 [12, 13] which uses the iron-
siderophore receptor FhuA to enter bacteria [14] and
inhibits RNA polymerase [15]. The ring part of the
MccJ25 lasso structure (Figure 1) results from an amide
bond between Gly1 and Glu8, and the C-terminal tail is
sterically blocked in the ring by the two bulky aromatic
side chains from Phe19 and Tyr20 on each side of the
ring [9], thus creating a b hairpin region over the ring.
Cyclization and folding into the particularly compact lasso
structure provide MccJ25 with exceptional resistance to
high temperatures, proteases, and chaotropic agents
[16]. They also define the functional regions of the mole-
cule implicated in recognition by the receptor FhuA at
the outer membrane of bacteria [14] and inhibition of tran-
scription by targeting the RNA polymerase b0 subunit [15].
These two properties are conferred by the Val11-Pro16
b hairpin [14] and the ring tail [17] of the MccJ25 lasso
structure, respectively.
A major advantage provided by MccJ25 for studying the
enzymes able to generate lasso peptides is that the
genetic determinants required for its production are
known. The mcjABCD gene cluster required for MccJ25
biosynthesis has been sequenced entirely [18] (Figure 1).
The gene mcjA encodes the linear 58 residue precursor
of MccJ25, whereas mcjD encodes an ATP-binding
cassette (ABC) transporter involved both in the export of
MccJ25 and in the self-protection of the producing strain
against the deleterious effects of its microcin. The last two
genes,mcjB andmcjC, encode proteins of unknown func-
tions. However, they are necessary for the production of
active MccJ25 and have been proposed to encode the
enzymes converting McjA into MccJ25 [19]. This process
comprises the cleavage of the precursor, the side chain to
backbone cyclization of the resulting C-terminal peptide,
and the three-dimensional structure acquisition of the
microcin (Figure 1).
In this study, we analyzed the effect of mcjB and
mcjC inactivation/complementation on the production of793–803, July 2007 ª2007 Elsevier Ltd All rights reserved 793
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McjA, the precursor of MccJ25, as well as McjB and
McjC, so as to examine their role in MccJ25 maturation.
RESULTS
McjC Is Expressed as a 513 Residue Protein
The genes mcjA, mcjB, and mcjC were amplified by poly-
merase chain reaction (PCR) from pTUC202 for cloning
into expression vectors. Surprisingly, PCR fragments
obtained for mcjC systematically displayed a deletion of
three bases in the gene encountered in the sequence pub-
lished for pTUC100, the vector from which the MccJ25
gene cluster was originally sequenced (EMBL accession
number AF061787). Following the sequencing of both
strands of pTUC202, which derives from pTUC100 [19],
it was found that the stop codon located 1327 bases after
the initiation codon in the mcjC sequence was erroneous
(see Figure S1 in the Supplemental Data available with
this article online) and was actually displaced 213 bases
further (GenBank accession number AM116873). From
the sequence data, mcjC is separated from mcjD by two
Figure 1. Biosynthesis of MccJ25
(A) Organization of the MccJ25 gene cluster. The genes mcjA (black
arrow), mcjB and mcjC (white arrows), and mcjD (hatched arrow)
encode the MccJ25 precursor McjA, putative maturation enzymes,
and the immunity/export protein, respectively. The promoters are indi-
cated by flags.
(B) MccJ25 maturation. McjA is subject to proteolytic cleavage and
formation of an amide bond between the amino group of Gly1 and
the carboxyl side chain of Glu8.
(C) Three-dimensional structure of MccJ25 (Protein Data Bank code
1Q71).794 Chemistry & Biology 14, 793–803, July 2007 ª2007 Elseviebases only, and encodes a 513 residue protein (instead
of 442) with a molecular mass of 58.7 kDa.
McjB and McjC Are Required for the Production
of MccJ25
In order to determine whether mcjB andmcjC are required
for MccJ25 maturation, each gene was inactivated by
insertion of a stop codon-containing oligonucleotide
duplex at a chosen site in pTUC202 (see Figure S2). The
resulting plasmids encoding truncated McjB (127 instead
of 208 amino acids) and McjC (52 instead of 513 amino
acids) were named pTUC202B and pTUC202C, respec-
tively. Culture supernatants from E. coli MC4100 harbor-
ing pTUC202, pTUC202B, or pTUC202C plasmids were
analyzed for the presence of MccJ25. Whereas the control
strain harboring pTUC202 displayed a strong antibacterial
activity specifically directed against the MccJ25-suscep-
tible strain, no MccJ25-specific activity could be detected
in culture supernatants from strains harboring pTUC202B
or pTUC202C (Figure 2). HPLC-MS analysis of the super-
natants confirmed that MccJ25, which is characterized by
a peak at 10.1 min, was absent from the culture superna-
tants of strains harboring either pTUC202B or pTUC202C,
but present in supernatants from the E. coli strain harbor-
ing the complete gene cluster (Figure 2). The pellets from
strains harboring pTUC202B or pTUC202C were devoid of
antibacterial activity (data not shown), which indicated
that disruption of either mcjB or mcjC did not result in
export failure but abolished MccJ25 production. The plas-
mids pET28-mcjB and pET28-mcjC, encoding His6-McjB
and His6-McjC, respectively, were further used to com-
plement E. coli MC4100 harboring pTUC202B and
pTUC202C, respectively. Both antibacterial assays and
HPLC-MS experiments clearly demonstrated that
MccJ25 production was restored upon complementation
(Figure 2). Altogether, these data indicate that both McjB
and McjC are required for MccJ25 production. Because
the sizes of the inhibition halos produced by comple-
mented strains were smaller than those of wild-type con-
trols, it was speculated that mcjB and mcjC inactivation
had a partial polar effect on their neighbor gene, as one
could expect for two genes proposed to be transcription-
ally and translationally coupled [18], and as has been
observed within the MccC7 gene cluster [20].
Recombinant Expression of His6-McjA
His6-McjA was produced as a cytosolic protein in E. coli
ER2566 harboring pET28-mcjA. In the first purification
step, using immobilized metal-affinity chromatography
(IMAC), His6-McjA was coeluted with various C-terminally
truncated forms due to the high sensitivity of McjA to pro-
teases. An additional RP-HPLC step permitted separation
of His6-McjA from the C-truncated fragments. Purity was
checked by MALDI-TOF-MS, which showed two peaks
at m/z 8231 and 4117, corresponding to the singly and
doubly protonated species, respectively, in agreement
with the mass calculated for His6-McjA (8232 Da; Fig-
ure 3A). The yield for His6-McjA expression and purification
was estimated at 150 mg/l of culture. Contrary to MccJ25,r Ltd All rights reserved
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In Vitro Reconstitution of a Lasso PeptideFigure 2. MccJ25 Production Is Abol-
ished upon Inactivation of mcjB or mcjC
and Restored by Complementation
Culture supernatants ofE. coliMC4100 harbor-
ing pTUC202, pTUC202B (inactivated mcjB),
pTUC202C (inactivated mcjC), pTUC202B
supplemented with pET28-mcjB, and
pTUC202C supplemented with pET28-mcjC
were analyzed by HPLC-MS on a Qq-TOF
mass spectrometer. The extracted-ion chro-
matograms for m/z 703, corresponding to the
MccJ25 [M+3H]3+ species, are presented
together with the antibacterial activities against
S. enterica serovar Enteritidis. MccJ25 is char-
acterized by the peak at 10.1 min.His6-McjA was devoid of antibacterial activity against the
MccJ25-susceptible strain (data not shown). The circular
dichroism (CD) spectrum of His6-McjA in aqueous solution
displayed a negative band at 198 nm, which indicated the
presence of a predominantly random coil conformation
(Figure 3B). However, the presence of SDS micelles trig-
gered the folding of the protein, which resulted in two neg-
ative bands at 206 and 223 nm, indicative of an a-helical
conformation (Figure 3B). Deconvolution of the CD spec-
trum of His6-McjA in SDS micelles indicated a helix content
in the 10%–15% range.
Recombinant Expression of His6-McjB
and His6-McjC
His6-McjB and His6-McjC were produced in E. coli
BL21(DE3) harboring pET28-mcjB and pET28-mcjC,
respectively. Generation of inclusion bodies was avoided
by growing the strains at 15C. Soluble His6-McjB and
His6-McjC purified using IMAC were analyzed by SDS-
PAGE. Their electrophoretic mobilities were in accor-
dance with their calculated molecular masses at 26.7
and 60.9 kDa for His6-McjB and His6-McjC, respectively
(see Figure S3). The identity of the purified proteins wasChemistry & Biology 14, 7assessed by in-gel digestion with trypsin. The peptide
fragments obtained for His6-McjB and His6-McjC covered
57% and 30% of the protein sequences, respectively, and
were distributed all along the sequences (see Figure S3).
The expression/purification yields were estimated at
40 mg and 200 mg/l of culture for His6-McjB and His6-
McjC, respectively. Given the efficient complementation
of inactivated mcjB and mcjC with DNA sequences
encoding His6-McjB and His6-McjC (see above), the re-
combinant proteins were used in further biochemical
studies without removal of the N-terminal His tag.
His6-McjB and His6-McjC Are Sufficient to Convert
His6-McjA into MccJ25 In Vitro
In vitro reconstitution of MccJ25 biosynthesis was done
by incubating His6-McjA with the potential maturation
enzymes His6-McjB and/or His6-McjC in the presence of
ATP and Mg2+. The ability of both proteins to generate
active MccJ25 from its inactive precursor His6-McjA was
monitored by antibacterial assays and HPLC-MS (Fig-
ure 4). The incubation of His6-McjA with either His6-McjB
or His6-McjC did not generate MccJ25. By contrast, anti-
bacterial activity was detected in the reaction mixture93–803, July 2007 ª2007 Elsevier Ltd All rights reserved 795
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McjC. This antibacterial activity resulted from the forma-
tion of MccJ25, as it was associated with the detection
of a triply charged ion at m/z 703 by HPLC-MS, corre-
sponding to the calculated mass for the [M+3H]3+ species
of MccJ25 (Figure 4). Interestingly, neither antibacterial
activity nor MccJ25 could be observed when a synthetic
linear MccJ25 corresponding to the 21 residue C-terminal
sequence of McjA was used as a substrate instead of
His6-McjA (data not shown).
HPLC-MS/MS analysis of the [M+3H]3+ ion of MccJ25
(m/z 703) confirmed that the in vitro-synthesized MccJ25
had acquired a lasso structure, that is, that the C-terminal
tail was threaded through the Gly1-Glu8 ring. This could
be ascertained given the typical fragmentation pattern of
lasso peptides [21]. HPLC-MS/MS profiles of MccJ25
secreted by E. coli and the in vitro-synthesized peptide
displayed identical retention times and fragmentation
patterns (Figure 5). Furthermore, several fragment ions
characteristic of the lasso structure were detected at
m/z 784.8, 813.4, 869.9, 940.1, and 997.4. Such ions
were identified as fragments generated by cleavages
within the peptide tail which consisted of tail segments
trapped in the Gly1-Glu8 ring, already described for the
naturally produced MccJ25 [9, 11].
Factors Affecting the Reconstitution of MccJ25
Biosynthesis
Among different pH and temperature conditions tested for
MccJ25 biosynthesis, the best were found to be 25C and
Figure 3. MS and CD Analysis of His6-McjA
(A) MALDI-TOF spectrum of recombinant His6-McjA.
(B) CD analysis of His6-McjA at 75 mM in 10 mM sodium phosphate
buffer (pH 7.4) in the absence (dotted line) or presence (solid line) of
8 mM SDS.796 Chemistry & Biology 14, 793–803, July 2007 ª2007 ElsevipH 8 (data not shown). Withdrawal of DTT, ATP, or MgCl2
from the reaction mixture impaired the conversion of His6-
McjA into MccJ25 by His6-McjB and His6-McjC (data not
shown). In order to better characterize the mechanism of
MccJ25synthesis, variousprotease inhibitorswere assayed
(fora reviewofprotease inhibitor specificity, seehttp://www.
serva.de/products/sheets/proteases.pdf), and the forma-
tion of MccJ25 was monitored by antibacterial assays. Pep-
statin A, EDTA, phosphoramidon, leupeptin, and E64 did
not prevent MccJ25 biosynthesis. By contrast, AEBSF (4-
[2-aminoethyl]-benzenesulfonyl-fluoride), as well as TLCK
(1-chloro-3-tosylamido-7-amino-2-heptanone) and TPCK
(1-chloro-3-tosylamido-4-phenyl-2-butanone), totally in-
hibited the formation of MccJ25 (data not shown).
Comparative Analysis of Amino Acid Sequences
Involved in the Maturation of MccJ25
In order to predict the function of each protein, similarity
searches were performed for McjA, McjB, and McjC
amino acid sequences using BLAST programs.
Figure 4. Reconstitution of MccJ25 Biosynthesis In Vitro
HPLC-MS analysis of reaction mixtures containing 0.5 nmol His6-McjA
alone or in the presence of 0.05 nmol His6-McjB and/or His6-McjC. The
extracted-ion chromatograms for m/z 703, corresponding to the
MccJ25 [M+3H]3+ species, are presented together with the antibacte-
rial activities against S. enterica serovar Enteritidis.er Ltd All rights reserved
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Collision-induced dissociation spectra of the triply charged m/z 703 precursor ion, obtained from HPLC-MS/MS analysis on an ion-trap instrument of
(A) MccJ25 purified from culture supernatants of the E. coli MC4100 pTUC202 strain and (B) in vitro-synthesized MccJ25 (product of His6-McjA
incubation with His6-McjB and His6-McjC). The main fragment ions consisting of two sterically linked peptides (tail fragments trapped in the Gly1-
Glu8 ring) are indicated in the table on the right.McjC (513 residues) exhibits 20%–22% identity (38%
similarity) between amino acids 31 and 376 to the C-termi-
nal domain of asparagine synthetase B (AS-B) from vari-
ous bacteria, including Burkholderia species [22, 23].
This domain of AS-B is involved in the synthesis of aspar-
agine from aspartic acid. However, McjC lacks the N-ter-
minal catalytic domain of AS-B which catalyzes the hydro-
lysis of glutamine to glutamic acid and ammonia. The
amino acid sequence of McjC was aligned with those of
AS-B from two Bacillus species and one E. coli, and with
a putative AS-B from Burkholderia thailandensis. Given
the similarity of the Gly1-Glu8 amide bond defining the
lasso ring to the amide bond found in b-lactam rings, three
b-lactam synthetases (b-LS) were also included in the
alignment. These include carbapenam synthetase (CarA)
from Erwinia carotovora and b-LS from Streptomyces
clavuligerus and Streptomyces cattleya, which catalyze
the formation of a b-lactam ring in carbapenems, clavu-
lanic acid, and thienamycin biosynthetic pathways,
respectively [24–26]. Two conserved motifs were identi-
fied in the multiple alignment (Figure 6A). These motifs
are located in the ATP- and substrate-binding sites of
the C-terminal synthetase domain, as deduced from the
three-dimensional structures of AS-B, CarA, and b-LS
[23, 27–29].
McjB (208 residues) contains two putative functional
regions. The N-terminal region up to position 133 is similar
(25% identity, 42% similarity) to certain adenosine kinases
from mammals. Further, the C-terminal region between
amino acids 146 and 200 displays 45% identity (62% sim-
ilarity) with several hypothetical proteins from Betaproteo-
bacteria (Burkholderia species), AlphaproteobacteriaChemistry & Biology 14,(Caulobacter species, Sphingopyxis alaskensis, Sphingo-
monas sp.), Gammaproteobacteria (Stenotrophomonas
maltophilia), and Actinobacteria (Streptomyces avermiti-
lis), one of which (NCBI RefSeqP ZP_01301928) is referred
to as a putative transglutaminase-like enzyme. Among
other reactions, transglutaminases catalyze the formation
of amide crosslinks between glutamine and lysine resi-
dues in proteins [30]. Transglutaminases belong to the
large family of cysteine proteases characterized by
a Cys-His-Asp catalytic triad [31]. This putative catalytic
triad is conserved among McjB and McjB-like proteins
from various bacteria (Figure 6B).
Surprisingly, as revealed by BLAST against the pepti-
dase database MEROPS [32], McjA (58 amino acids)
exhibits similarities with two regions of a large serine
C-terminal processing peptidase-3 from Flavobacteriales
bacterium HTCC2170 (MEROPS accession number S41.
004; NCBI RefSeqP ZP_01105541). However, the active
site of this peptidase family is not present in McjA.
Gene clusters similar to that of MccJ25 were found in
various bacterial genomes. Neighborhood analysis of
McjB-like proteins by the STRING program [33] revealed
functional association of an McjB-like protein with both
an AS-B (Swiss-Prot accession number Q2SVT9) and
an ABC transporter (Swiss-Prot accession number
Q2SVT8) in B. thailandensis E264. These are similar to
McjC and McjD, respectively, and encoded, as in the
MccJ25 gene cluster, by two genes located downstream
of the mcjB-like gene in the complete genome (GenBank
accession number CP000086). Moreover, a small open
reading frame (ORF) was identified upstream of this
mcjB-like gene. It encodes a putative 47 amino acid793–803, July 2007 ª2007 Elsevier Ltd All rights reserved 797
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In Vitro Reconstitution of a Lasso PeptideFigure 6. McjC, McjB, and McjA Sequence Similarities
(A and B) Multiple alignments for McjC and McjB. Numbers in angle brackets refer to the length in amino acids of unaligned regions. Letters on black
and gray backgrounds highlight identical amino acids and similarity, respectively. All accession numbers of amino acid sequences are from the Swiss-
Prot database.
(A) Alignment of similar regions of McjC, asparagine synthetases B (AS-B), and b-lactam synthetases (b-LS). BACSU, AS-B from Bacillus subtilis
(P54420); BACLD, AS-B from Bacillus licheniformis (Q65FV9); ECOLI, AS-B from E. coli (P22106); CarA, carbapenem synthetase from Erwinia car-
otovora (Q9XB61); STRCL, b-LS from Streptomyces clavuligerus (Q9R8E3); ThnM, b-LS from Streptomyces cattleya (Q83XP1); BURTA, putative
AS-B from Burkholderia thailandensis (Q2SVT9); and McjC, from E. coli (Q333M5; this study). The stars indicate amino acids involved in Mg2+ coor-
dination and ATP binding.
(B) Alignment of McjB and McjB-like proteins. The stars indicate the catalytic triad of putative cysteine proteases [31]. McjB-like proteins are BURPS,
from Burkholderia pseudomallei BPSL1795 (Q63U22); BURTA, from B. thailandensis E264 (Q2SVU0); 9CAUL, from Caulobacter sp. K31 (Q0LZ71);
SPHAL, from Sphingopyxis alaskensis (Q1GPW3); 9SPHN, from Sphingomonas sp. SKA58 (Q1NGU8); XANMA, from Stenotrophomonas maltophilia
(A1FRG0); STRAW, from Streptomyces avermitilis (Q82L14); and McjB, from E. coli (Q9X2V8).
(C) Alignment of the MccJ25 precursor, McjA (Q9X2V7), with putative peptides whose C-terminal region displays conserved features of lasso pep-
tides. BURTA, 47 amino acid peptide from B. thailandensis; BURPS and BURMA, 47 amino acid peptide from B. pseudomallei and B. mallei, respec-
tively; CAULO, 44 amino acid peptide from Caulobacter sp. K31 (Q0LUL4), SPHAL, 44 amino acid peptide from Sp. alaskensis. The arrow indicates
the known or putative cleavage site of lasso peptide precursors. Light shading indicates known or putative acid and aromatic residues involved in the
amide bond and trapping of the tail in the ring, respectively.peptide with a 19 residue C-terminal sequence reminis-
cent of lasso peptide sequences (Figure 6C). In this puta-
tive lasso peptide sequence, an N-terminal glycine can be
involved in an amide bond with the side chain of aspartic
acid at position 9, while, as in MccJ25, two aromatic
amino acids (Phe16 and Phe18) located within the C termi-
nus could be involved in the trapping of the tail in the ring.
Similar gene clusters encoding the same putative lasso
peptide were identified in Burkholderia pseudomallei
K96243, 1710b, 668, and 1106a and Burkholderia mallei
ATCC23344 complete genomes (GenBank accession798 Chemistry & Biology 14, 793–803, July 2007 ª2007 Elsevienumbers BX571965, CP000124, CP000570, CP000572,
and CP000010, respectively). However, an mcjD-like
gene is lacking in the B. mallei genome. It is noteworthy
that, contrary to the MccJ25 gene cluster (Figure 1A),
the gene clusters encountered in Burkholderia species
are organized in a single transcription unit. Finally, other
putative lasso peptide gene clusters were identified in
Caulobacter sp. K31 (GenBank accession number
AATH01000007) and Sp. alaskensis RB2256 (GenBank
accession number CP000356) genomes, but, like B. mal-
lei, the mcjD-like genes are lacking.r Ltd All rights reserved
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The unusual lasso three-dimensional structure of MccJ25
has been the subject of major interest [9–11]. In this article,
we show that only two enzymes encoded by the MccJ25
gene cluster, namely McjB and McjC, are sufficient for
the conversion of McjA, the 58 residue linear precursor
of MccJ25, into the lasso-structured MccJ25 endowed
with antibacterial activity. To our knowledge, this is the
first example of the in vitro reconstitution of a lasso pep-
tide biosynthesis.
A major result from this article is that no other protein but
McjB and McjC is necessary to convert McjA into MccJ25.
This was clearly shown here by the in vitro generation of
a lasso-structured and biologically active MccJ25 from
the inactive linear His6-McjA upon addition of His6-McjB
and His6-McjC. It therefore appears that the MccJ25-ded-
icated maturation machinery is encoded by the MccJ25
gene cluster alone. It thus differs from other class I micro-
cins [13], namely microcin B17 (MccB17) and microcin C7/
C51 (MccC7/C51), whose precursors are cleaved by pro-
teases that are not encoded by their respective gene clus-
ter but are either chromosome encoded by the producing
bacteria (MccB17) or expressed by the target bacteria
(MccC7/C51). A relevant inference from our in vitro data
is that MccJ25 maturation is completely independent of
the export mechanism. Indeed, McjD, which is responsi-
ble for the export of MccJ25 into the extracellular medium,
is not required to convert His6-McjA into MccJ25. This
finding contrasts with the processing of class II microcins,
which requires the complete export machinery to cleave
the precursor from its leader peptide concomitant with se-
cretion [13].
The respective function of McjB and McjC was exam-
ined using mcjB- or mcjC-mutated strains. Indeed, in the
hypothesis of two enzymes working independently, one
of the mutated strains would be expected to accumulate
unprocessed McjA while the other would produce linear
MccJ25. Unfortunately, we could not detect either McjA
or linear MccJ25 in cell pellets and culture supernatants
from these strains. However, it cannot be ruled out that
inactivation of mcjB or mcjC affects mcjA transcription.
The genes mcjA and mcjBCD are two independent tran-
scription units (Figure 1A), and rapid intracellular degrada-
tion of McjA or linear MccJ25 could explain their absence
in pellets and supernatants, as observed during the purifi-
cation of His6-McjA. Similarly, instability of microcin pre-
cursors in strains deficient for the processing machinery
has been reported for the precursors of MccB17 and mi-
crocin V [34, 35].
Insight into the molecular mechanisms of MccJ25 mat-
uration was obtained by similarity searches and multiple
alignments for McjB and McjC. Given its similarity to AS-B
and b-LS, McjC is likely to be involved in the formation
of the amide bond between Gly1 and Glu8. MccJ25 mat-
uration requires ATP and Mg2+, as AS-B and b-LS do [23,
25, 27–29]. Therefore, we propose that McjC belongs to
the family of ATP/Mg2+-dependent amide synthesizing
enzymes. Because AS-B and b-LS catalyze intermolecu-Chemistry & Biology 14,lar and intramolecular amide bond formation, respec-
tively, McjC catalytic function is more related to b-LS. As
with these enzymes [27–29, 36, 37], the reaction would in-
volve an Mg2+-facilitated adenylation of the g-carboxylate
of Glu8, followed by cyclization via a tetrahedral transition
state or an oxyanion intermediate. Based on the conserva-
tion of residues located in the b-LS catalytic site (Figure 6A)
[23, 27–29], it can be inferred that the side-chain oxygens
of Asp203 and Asp302 from McjC coordinate the Mg2+
ion, which also interacts with the negatively charged
phosphates from ATP. Furthermore, the amide nitrogen
of Gly298 and the side-chain hydroxyl groups of Ser199
and Ser204 can interact with adenosine and phosphates
from ATP, respectively.
The enzyme responsible for McjA proteolytic cleavage
could not be unambiguously identified from this study.
On the one hand, we showed that the C-terminal region
of McjB contains the Cys150-His182-Asp194 putative
catalytic triad of cysteine proteases. On the other hand,
MccJ25 in vitro synthesis was blocked by serine protease
inhibitors rather than cysteine protease inhibitors. There-
fore, the catalytic triad might not involve Cys150 but rather
Ser154, located nearby. Further, an autolytic activity of
McjA in complex with McjB and McjC cannot be ruled
out at this stage, as McjA displays some features of a
serine C-terminal processing peptidase-3.
Note that, given the steric trapping of the C-terminal tail
in the Gly1-Glu8 ring in MccJ25, the amide bond formation
requires the previous positioning of the (1) Gly1 amino
group and Glu8 carboxylate and (2) Phe19 and Tyr20 aro-
matic side chains. As only McjB and McjC are responsible
for MccJ25 maturation, the correct positioning of the C-
terminal tail is likely to result from the interaction of McjA
with one of the modification enzymes, and not to rely on
a chaperone protein.
Contrary to McjA, the 21 residue linear MccJ25 was
shown not to be a substrate for His6-McjB and His6-
McjC, suggesting that the 37 residue leader peptide of
McjA is required for the maturation. Therefore, the N-ter-
minal leader peptide of the microcin precursor is likely to
be involved in the recognition by the modification en-
zymes rather than the export machinery. This is similar
to MccB17 [34] and in contrast with class II microcins [13].
Several peptides displaying the same internal side chain
to backbone linkage as MccJ25 were isolated from micro-
bial sources. Although nothing is known about the biosyn-
thesis of these peptides, their occurrence suggests that
similar enzymatic machineries could be involved. In this
study, putative lasso peptide gene clusters (either com-
plete or partial) were identified in the genome of several
Proteobacteria not belonging to the Enterobacteria.
Except for MccJ25, all the previously described [7, 8] and
the putative lasso peptides are produced by bacteria
widely distributed in nature, especially in soil or water.
Thus, the MccJ25 gene cluster may have been acquired
from these environmental bacteria. The widespread gene
clusters encoding putative lasso peptide machineries sug-
gest their conservation during evolution and raise the
question of whether lasso peptides observed in various793–803, July 2007 ª2007 Elsevier Ltd All rights reserved 799
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is, whether they display antimicrobial properties.
SIGNIFICANCE
Naturally occurring lasso peptides display a complex
structure with a side chain to backbone internal link-
age forming an N-terminal ring (8 or 9 residues) in
which the C-terminal tail is irreversibly threaded.
Most of them are enzyme inhibitors produced by
Streptomyces species. MccJ25 is such a lasso pep-
tide. Gene-encoded and secreted by Escherichia coli
AY25, it exerts a potent antibacterial activity by block-
ing bacterial RNA polymerase. Here we demonstrate
that two enzymes, namely McjB and McjC, encoded
by genes belonging to the MccJ25 gene cluster act
in concert to convert the precursor McjA into
MccJ25 through a process that requires ATP and
Mg2+. To our knowledge, this is the first in vitro recon-
stitution of a lasso peptide biosynthesis. Our results
question the possibility of a common ribosomal bio-
synthetic pathway leading to lasso peptides in differ-
ent Proteobacteria and Actinobacteria involving
a catalytic mechanism similar to that of b-lactam
synthetases.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmids
Strains and plasmids are described in Table S1. Production of
recombinant proteins was done in either E. coli BL21(DE3) or E. coli
ER2566 (Novagen). MccJ25 production as well as gene inactivation
and complementation assays were performed in E. coli MC4100 (lab-
oratory collection). For mcjB and mcjC complementation, bacteria
were transformed with either the mcjB-encoding pET28-mcjB plasmid
or the mcjC-encoding pET28-mcjC plasmid (this study; see construc-
tion below). Antibiotics were purchased from Sigma and used at the
following concentrations: ampicillin, 50 mg/ml; chloramphenicol,
34 mg/ml; kanamycin, 50 mg/ml; and tetracycline, 50 mg/ml.
Antibacterial Assays
MccJ25-specific antibacterial activity was detected by radial diffusion
assay against the microcin-susceptible Salmonella enterica serovar
Enteritidis and the microcin-resistant E. coli MC4100 pTUC202. A
gel overlay was prepared by inoculating 10 ml M63 medium (6.5 g/l
agar) with 107 colony-forming units per ml of bacteria in exponential
phase of growth. Petri dishes containing 20 ml M63 medium (15 g/l
agar) were overlaid with the bacterial suspension. After solidification,
fractions to be analyzed (10 ml of boiled culture supernatant or enzy-
matic reaction mixtures) were placed onto the overlay. After a 16 hr in-
cubation at 37C, plates were analyzed for the presence of inhibition
halos. Fractions inhibitory to S. enterica serovar Enteritidis but not to
E. coli MC4100 pTUC202 were considered to contain MccJ25.
Gene Disruption of mcjB and mcjC
The plasmid pTUC202 was digested at one single site withinmcjB with
BstXI. Stop codons were inserted at this site (371 bases after the mcjB
initiation codon) by insertion of an oligonucleotide duplex complemen-
tary to the BstXI-generated cohesive ends (see Figure S2). The duplex
was generated with two complementary 50-phosphorylated oligonu-
cleotides (50-GAGCTCGAGTAATAGTAGGGG-30 and 50-TTCCCC
CTACTATTACTCGAG-30) designed to introduce an Xhol site and abol-
ish the BstXI site after insertion. Prior to transformation, pTUC202 plas-
mids lacking the insert were eliminated by digestion with BstXI. The800 Chemistry & Biology 14, 793–803, July 2007 ª2007 Elseviepositive clones were selected by restriction map comparison. One
positive clone carrying an inactivated mcjB gene was selected for
MccJ25 expression studies. A similar strategy was used for mcjC dis-
ruption. Briefly, pTUC202 was digested with SapI (156 bases after the
mcjC initiation codon) and ligated to a duplex generated with 50-phos-
phorylated oligonucleotides (50-TAATAGTCACTCGAGAGTA-30 and
50-CTCGAGTGACTATTATACT-30) (see Figure S2). One positive clone
carrying an inactivated mcjC gene was selected.
Construction of Plasmids Encoding His6-McjA, His6-McjB,
and His6-McjC
Plasmids encoding McjA, McjB, and McjC with an N-terminal fusion
of six histidines were constructed. Basically, mcjA, mcjB, and mcjC
were amplified from pTUC202 using the forward primers mcjANdeI
(50-GCCCATATGATTAAGCATTTTC-30), mcjBNdeI (50-CATATGATCC
GTTACTGCTTAAC-30), and mcjCNdeI (50-CCATATGGAAATATTTAA
TGTCAAG-30), respectively, as well as the reverse primers mcjAXhoI
(50-CTCGAGAATATCAGCCATAGAAAG-30), mcjBXhoI (50-CTCGAG
CTATATCTCTGCAATAAC-30), and mcjCXhoI (50-CTCGAGTTAACC
TTTATAATCAATG-30), respectively. The forward and reverse primers
introduced NdeI and XhoI restriction sites (underlined), respectively.
PCR reactions, performed in an Eppendorf Mastercycler, included
30 cycles: 94C for 45 s, 45C for 45 s, and 72C for 45 s. The amplified
fragments were cloned into the pMOSBlue plasmid (GE Healthcare) for
sequencing and subcloned into the pET28b expression vector (Nova-
gen) by NdeI/XhoI double digestion.
Expression and Purification of Recombinant His6-McjA,
His6-McjB, and His6-McjC
The pET28b derivatives encoding His6-McjA, His6-McjB, and His6-
McjC were used to freshly transform E. coli ER2566 (for pET28-
mcjA) or E. coli BL21 (for pET28-mcjB and pET28-mcjC). Cells were
grown at 37C in LB medium supplemented with kanamycin. At the
optical density of 0.6 at 600 nm, 1 mM IPTG (QBiogen) was added
and cells were further incubated for 1 hr at 37C (His6-McjA) or 16 hr
at 15C (His6-McjB and His6-McjC). Cells were harvested by centrifu-
gation at 4C (50003 g, 20 min) and resuspended in chilled lysis buffer
(50 mM sodium phosphate [pH 8], 500 mM NaCl) supplemented with
an EDTA-free protease inhibitor cocktail (Roche), 5 mg/ml DNase
(Roche), and 10 mg/ml RNase (Sigma). His6-McjA-producing cells
were heated at 100C for 10 min to prevent enzymatic degradation.
Cells were broken in a French press (Thermo Electron) and cell debris
were removed by centrifugation (50,000 3 g, 30 min). Supernatants
were subjected to affinity chromatography on a HisTrap HP column
(GE Healthcare) pre-equilibrated with 20 mM (His6-McjB and His6-
McjC) or 40 mM imidazole (His6-McjA) in lysis buffer. After loading of
the bacterial lysate supernatants, the resin was washed with 80 mM
imidazole in lysis buffer and the His-tagged proteins were eluted by in-
creasing the imidazole concentration to 200 mM. Purification at 4C
was monitored by measuring absorbance at 280 nm.
Fractions containing His6-McjA were desalted by solid-phase
extraction on a SepPak C8 cartridge (Waters Corporation) pre-equili-
brated with 0.1% aqueous TFA (trifluoroacetic acid). The cartridge
was washed with 0.1% aqueous TFA prior to elution with 20% and
40% acetonitrile (ACN) in 0.1% aqueous TFA. The 40% SepPak frac-
tion was vacuum dried (SpeedVac; Savant) and His6-McjA was purified
by RP-HPLC on a mBondapak C18 column (10 mm, 300 3 3.9 mm;
Waters Corporation). Separation was performed at a flow rate of
1 ml/min under the following biphasic gradient: 0%–25% ACN in
0.1% aqueous TFA in 2 min and 25%–45% ACN in 0.1% aqueous
TFA in 25 min. Purification was monitored by UV detection at 226
nm and fractions were hand collected. Purity was controlled by
SDS-PAGE and MALDI-TOF-MS.
Fractions containing His6-McjB or His6-McjC were desalted by
extensive dialysis against 50 mM sodium phosphate (pH 8), 100 mM
NaCl. Purity was assessed by SDS-PAGE.r Ltd All rights reserved
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His6-McjA was quantified on a Uvikon 932 spectrophotometer (Kon-
tron Instruments), assuming a theoretical molar extinction coefficient
of 2560 M1 cm1 at 280 nm. His6-McjB and His6-McjC were quanti-
fied by the Bradford assay with a Coomassie protein assay kit (Pierce).
SDS-PAGE Analysis
Tris-tricine SDS-PAGE (16.5% acrylamide) was performed for His6-
McjA [38], whereas Tris-glycine SDS-PAGE (10%–12% acrylamide)
was performed for His6-McjB and His6-McjC [39]. Proteins were visu-
alized by silver or Coomassie blue staining. The molecular-weight
markers were a polypeptide standard (Bio-Rad) for His6-McjA and
a broad-range protein marker (New England Biolabs) for His6-McjB
and His6-McjC.
In-Gel Trypsin Digestion
Protein bands were excised from SDS-PAGE and washed twice with
25 mM NH4HCO3 (pH 8), once with 50% ACN in 25 mM NH4HCO3
(pH 8), once again with 25 mM NH4HCO3 (pH 8), and finally with H2O
before being vacuum dried. Gel slices were rehydrated with 50 ml
digestion buffer (25 mM NH4HCO3 [pH 8.0], 5 mM CaCl2 containing
20 ng/ml trypsin from bovine pancreas [Sigma T8642]) and incubated
for 16 hr at 37C with vigorous shaking. Supernatants were collected.
Gels were washed once with 0.1% aqueous FA (formic acid) and once
with ACN, and extracts were combined to the formerly collected
supernatants. The pooled supernatants were vacuum dried, resus-
pended in 15 ml 0.1% aqueous FA, and desalted on C18 tips (Omix;
Varian) before MALDI-TOF-MS analysis.
In Vitro Enzymatic Assays for MccJ25 Synthesis
Freshly prepared His6-McjA or linear MccJ25, the 21 residue C-termi-
nal sequence of McjA [16] (0.5 nmol), was incubated for 150 min at
25C in the absence or presence of 0.05 nmol His6-McjB and/or
His6-McjC in 50 mM sodium phosphate (pH 8), 1 mM DTT, 1 mM
ATP, 1 mM MgCl2 (1 ml). To determine the nature of the enzymatic ac-
tivities, different protease inhibitors were added to the reaction mix-
ture, namely AEBSF (0.25 mM), TPCK (3.5 mM), TLCK (3.5 mM), E64
(12.5 mM), leupeptin (2.5 mM), phosphoramidon (12.5 mM), EDTA
(0.5 mM), or pepstatin (25 mM). All were from Sigma, except AEBSF
(Alexis Biochemicals). Assays were also done in the absence of ATP
or MgCl2, or at 15
C or 25C, or pH 5 or 7. Solid-phase extraction on
SepPak C8 cartridges (Waters Corporation) was performed for desalt-
ing. The reaction mixtures, acidified with 0.1% aqueous FA, were
loaded and successively eluted with 5 ml 0.1% aqueous FA, and 5
ml 10% ACN and 3 ml 90% ACN in 0.1% aqueous FA. The last fraction
was vacuum dried and resuspended in 50 ml 10% ACN in 0.1% aque-
ous FA prior to HPLC-MS analysis.
MALDI-TOF Mass Spectrometry
Experiments were done on a Voyager DE-PRO or a 4800 TOF/TOF
instrument (Applied Biosystems). One microliter of matrix solution
(a-cyano-4-hydroxycinnamic acid or sinapinic acid dissolved at
10 mg/ml in 30% ACN in 1% aqueous FA) was mixed with 1 ml of pro-
tein solution or 1 ml of trypsin digest. The mass spectrometer was
operated in positive-ion mode with a 25 kV accelerating voltage, either
in reflectron mode for His6-McjB and His6-McjC trypsin digests or in
linear mode for His6-McjA. The mass spectrometer was calibrated
either internally with the ions corresponding to trypsin autodigestion
for trypsin digests or externally with a peptide mixture (calibration mix-
ture 3; Applied Biosystems) for His6-McjA.
HPLC-MS and HPLC-MS/MS Experiments
HPLC-MS experiments were done on a Perkin Elmer chromatographic
system (Series 200) connected to an Agilent 1100 UV detector and a
Q-STAR Pulsar Qq-TOF mass spectrometer equipped with an ion-
spray source (Applied Biosystems). The separation was achieved on
a Hypersil Gold C18 column (1.9 mm, 50 3 2.1 mm; Thermo Electron).
The elution gradient was 10%–60% ACN in 0.1% FA over 10 min atChemistry & Biology 14,a flow rate of 0.25 ml/min. The UV detection was set up at 226 nm
and a post-UV split directed 50 ml/min of the effluent to the MS instru-
ment, operated in positive mode over the range m/z 250–1500. HPLC-
MS/MS experiments were done on the species at m/z 703 with a 22.5 V
collision energy. Alternatively, HPLC-MS and HPLC-MS/MS experi-
ments were conducted on an Agilent 1100 series HPLC system con-
nected to an Esquire 3000 ion trap mass spectrometer equipped
with an electrospray ionization (ESI) source, with the same separation
conditions. HPLC-MS/MS experiments were done on the species at
m/z 703 with a resonant excitation amplitude of 0.85 VP-P.
Circular Dichroism
CD spectra were acquired on a Jasco J-810 spectropolarimeter equip-
ped with a PFD 423S/L Peltier-type temperature controller. His6-McjA
samples, dissolved at 75 mM in 10 mM sodium phosphate buffer
(pH 7.4) in the absence or presence of 8 mM SDS, were placed in a
0.05 cm path quartz cell and analyzed at 25C over the 190–250 nm
range. The spectra were acquired at 50 nm/min, with 1 s response
time, 2 nm band width, and three scans averaged per sample. CD con-
tribution from the buffer was subtracted, and CD signals were normal-
ized to protein concentration and expressed as the mean residue
weight ellipticity, [q]. The CD spectra were deconvoluted with the dif-
ferent programs provided by DICHROWEB [40], DICHROPROT [41],
and CDPro [42] to assess the helix content in the protein structure.
Sequence Analysis
Similarity searches for McjB and McjC (this study) were performed us-
ing the BLAST programs [43, 44] at the National Center for Biotechnol-
ogy Information. Multiple sequence alignment was performed using
the CLUSTAL W program [45] with the Gonnet 250 matrix to find highly
conserved amino acid sequences. ORFs of more than 100 bases were
predicted by ORF Finder at NCBI followed by a similarity search with
BLASTP. Searches of proteins associated with McjB-like proteins
were performed using the STRING (Search Tool for the Retrieval of In-
teracting Proteins) program [33] at the European Molecular Biology
Laboratory (http://string.embl.de/). Searches for genes neighboring
the mcjB-like genes were also performed manually. Putative proteo-
lytic activity of McjA was investigated by a BLASTP search against
the peptidase database MEROPS [32] at the Sanger Institute (http://
merops.sanger.ac.uk/).
Supplemental Data
Supplemental Data include three figures and one table and can be
found with this article online at http://www.chembiol.com/cgi/
content/full/14/7/793/DC1/.
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